🎁 Black Friday: up to 50% off of annual plans
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026

BIONET Therapeutics Statistics

Total Valuation

TPEX:7808 has a market cap or net worth of TWD 2.07 billion. The enterprise value is 1.08 billion.

Market Cap2.07B
Enterprise Value 1.08B

Important Dates

The next estimated earnings date is Friday, March 19, 2027.

Earnings Date Mar 19, 2027
Ex-Dividend Date n/a

Share Statistics

TPEX:7808 has 70.00 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class 70.00M
Shares Outstanding 70.00M
Shares Change (YoY) +1.91%
Shares Change (QoQ) n/a
Owned by Insiders (%) 5.89%
Owned by Institutions (%) 1.91%
Float 35.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.78
PB Ratio 1.75
P/TBV Ratio 1.75
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.08
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.98, with a Debt / Equity ratio of 0.02.

Current Ratio 15.98
Quick Ratio 15.05
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -166.41

Financial Efficiency

Return on equity (ROE) is -5.77% and return on invested capital (ROIC) is -4.45%.

Return on Equity (ROE) -5.77%
Return on Assets (ROA) -5.42%
Return on Invested Capital (ROIC) -4.45%
Return on Capital Employed (ROCE) -7.21%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count105
Asset Turnover 0.17
Inventory Turnover 2.14

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.14% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -47.14%
50-Day Moving Average 35.85
200-Day Moving Average 39.04
Relative Strength Index (RSI) 27.22
Average Volume (20 Days) 14,972

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7808 had revenue of TWD 211.96 million and -69.24 million in losses. Loss per share was -0.99.

Revenue211.96M
Gross Profit 120.01M
Operating Income -86.78M
Pretax Income -69.24M
Net Income -69.24M
EBITDA -63.94M
EBIT -86.78M
Loss Per Share -0.99
Full Income Statement

Balance Sheet

The company has 1.02 billion in cash and 22.52 million in debt, with a net cash position of 994.36 million or 14.21 per share.

Cash & Cash Equivalents 1.02B
Total Debt 22.52M
Net Cash 994.36M
Net Cash Per Share 14.21
Equity (Book Value) 1.19B
Book Value Per Share 17.33
Working Capital 1.05B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.49 million and capital expenditures -23.67 million, giving a free cash flow of -49.16 million.

Operating Cash Flow -25.49M
Capital Expenditures -23.67M
Depreciation & Amortization 22.85M
Net Borrowing -3.32M
Free Cash Flow -49.16M
FCF Per Share -0.70
Full Cash Flow Statement

Margins

Gross margin is 56.62%, with operating and profit margins of -40.94% and -32.67%.

Gross Margin 56.62%
Operating Margin -40.94%
Pretax Margin -32.67%
Profit Margin -32.67%
EBITDA Margin -30.16%
EBIT Margin -40.94%
FCF Margin n/a

Dividends & Yields

TPEX:7808 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -1.91%
Shareholder Yield -1.91%
Earnings Yield -3.34%
FCF Yield -2.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3